Strategies for Overcoming Scientific, Regulatory and Business Challenges in Early Drug Development
October 18, 2010Barcelona, Spain
BARCELONA
Monday October 18, 2010
13:30 – 18.00 hrs
Venue:
Centro de Negocios
Aeropuerto de Barcelona Terminal 1,
Meeting Room: "Airmeetings 5"
08820 El Prat de Llobregat
What you will Learn
- What funding models are available to companies at a National and European level
- How to stratify your preclinical development plan
- Strategic and tactical solutions for accelerating early phase research programs
- Success routes in partnering with a CRO at early development stages
Agenda
CRO partnering - how to make partnering with CRO a success within early clinical drug development
Cadidad Pontes, MD, PhD, Head of Clinical Research and Regulatory Affairs, PALAU Pharma S.A.
Non-clinical and regulatory strategies to support early clinical development
Dr Anders Neil, Principal Consultant Early Stage, PAREXEL Consulting
Identification and Mitigation of Risks in First-in-Human Clinical Trials - Pitfalls and Challenges
Dr Matthias Grossmann, Vice President and Principal Consultant Early Phase, PAREXEL International
This event is free of charge to members of the biopharmaceutical industry.
PAREXEL Speakers Bureau
PAREXEL is your reliable source for knowledgeable speakers on issues affecting the pharmaceutical, biological, and medical device industries.
In addition to being leading subject matter experts, members of the PAREXEL team are experienced at delivering lively and compelling presentations to a broad range of audiences. If you need a speaker for an upcoming event, please click here.